David A. Sinclair
PulseAugur coverage of David A. Sinclair — every cluster mentioning David A. Sinclair across labs, papers, and developer communities, ranked by signal.
- 2026-06-09 research_milestone David Sinclair plans to initiate human trials for a whole-body rejuvenation drug as part of the XPrize Healthspan Competition. source
- 2026-06-09 research_milestone David Sinclair plans to initiate human trials for an oral rejuvenation drug as part of the XPrize Healthspan Competition. source
1 day(s) with sentiment data
-
Longevity research challenges traditional retirement age, wealth transfer timelines
New research suggests that the traditional retirement age of 65 is becoming obsolete due to increasing human longevity, with some experts predicting lifespans of up to 130 years. A Longevity Preparedness Index developed…
-
Geneticist's age-reversal eye therapy enters human trials
Yuancheng (Ryan) Lu, a geneticist at the Whitehead Institute, has developed a gene therapy that shows promise in reversing age-related vision loss. His technique, based on reprogramming cells using a modified set of Yam…
-
19-Year-Old Leverages AI to Outperform Professors, Discussed by Williamson and Sinclair
A 19-year-old student has reportedly used artificial intelligence to surpass their professors' understanding in certain academic areas. This development was discussed by Chris Williamson and Dr. David Sinclair, who touc…
-
Longevity research attracts billions for cellular rejuvenation therapies
Scientists are exploring methods to reverse aging by returning cells to a younger state, attracting significant investment. This field, known as longevity research, is rapidly advancing with experimental treatments aimi…
-
Longevity field's cellular reprogramming theory faces human trial reality check
A groundbreaking human trial has begun for a gene therapy aimed at partially reprogramming older cells to a younger state, a development that could validate key theories in the longevity medicine field. This early-stage…
-
MIT Tech Review: Cell reprogramming for aging reversal and interoception research gain momentum
MIT Technology Review's newsletter, The Download, highlights two emerging areas of scientific research: the "reprogramming" of cells to reverse aging and the study of interoception, the internal sense of bodily feelings…
-
OpenAI Files for $1 Trillion IPO Amid AI and Longevity News
MIT Technology Review's daily newsletter, The Download, covers significant developments in AI and longevity research. The publication highlights OpenAI's confidential filing for a US IPO, potentially valuing the company…
-
David Sinclair to test oral rejuvenation drug in XPrize competition
Longevity scientist David Sinclair is preparing to test an oral drug mixture, code-named SL-100, for whole-body rejuvenation. This initiative is part of a $101 million XPrize competition aimed at restoring individuals t…